GIA
EWTX icon

GHP Investment Advisors’s Edgewise Therapeutics EWTX Stock Holding History

GHP Investment Advisors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122 Hold
3
– – ﹤0.01% 1250
2026
Q1 		$95 Buy
+3
New +$87 ﹤0.01% 1307

Other funds holding EWTX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

GHP Investment Advisors's EWTX Position: Q2 2026 in Review

GHP Investment Advisors held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 3 shares worth $122. The position accounts for ﹤0.01% of the portfolio, ranked #1250.

GHP Investment Advisors first reported a position in EWTX in Q1 2026 and has held it in 2 quarters since. 34 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • GHP Investment Advisors held 3 shares of Edgewise Therapeutics worth $122 as of Q2 2026.
  • GHP Investment Advisors left its Edgewise Therapeutics share count unchanged in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1250 holding.
  • GHP Investment Advisors first reported a position in Edgewise Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 34 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.